AMYRIS

In News

Amyris Buys Ingredion’s Stake in the Real Sweet Joint Venture - MSN

MSN - Jul 02, 2025

Amyris Assumes Full Control of Brazilian Plant, Ingredion Gains Sole Access to Fermentation Tech - vegconomist - the vegan business magazine

vegconomist - the vegan business magazine - May 30, 2025

Lawsuit claims Amyris' downfall linked to CEO's risky deals and silencing of dissenting voices - The Business Journals

The Business Journals - Apr 02, 2025

Amyris Awarded Agreement from BioMaP-Consortium to Develop Critical Medicines to Support Resilient Domestic Supply Goals - PR Newswire

PR Newswire - Oct 03, 2024

Amyris Seizes the Sweet Spot: How Vertical Integration Could Sweeten Synthetic Biology's Bottom Line - AInvest

AInvest - May 30, 2025

Amyris Ch. 11 Trust Sues Ex-CEO Over $200M Skin Care Deal - Law360

Law360 - Apr 10, 2025

ONE WEEK DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire

ACCESS Newswire - Jul 05, 2025

Amyris Lands $12.3M to Tackle U.S. Drug Shortages Through Synthetic Biology - SynBioBeta

SynBioBeta - Oct 04, 2024

Synthetic biology, once hailed as a moneymaker, meets tough times - Science | AAAS

Science | AAAS - Aug 22, 2024

Ginkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris' Path (NYSE:DNA) - Seeking Alpha

Seeking Alpha - Jan 30, 2025

APRINNOVA – A joint venture of AMYRIS and NIKKOL Group - Cosmetics Design North America

Cosmetics Design North America - Nov 21, 2024

Amyris gains sole control of Brazilian fermentation facility - Investing.com

Investing.com - May 29, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.